StockVS

Daedalus Special Acquisition Corp. (DSAC) 股票分析

金融服务

Daedalus Special Acquisition Corp.

$9.96

+$0.01 (+0.10%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Daedalus Special Acquisition Corp. operates exclusively within the financial services sector, specifically categorized under the industry of shell companies, with a primary business focus on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses. The company was incorporated in 2025 and currently lacks significant ongoing operations outside of its strategic mandate to complete such business combinations. Its current market capitalization stands at $337.12 million, while the available data indicates no reported annual revenue and an employee count listed as not applicable, which is typical for pre-transaction special purpose acquisition companies. These financial metrics suggest that the company's valuation is primarily driven by market expectations of a future business combination rather than current operational cash flows or revenue generation, reflecting the transitional nature of its shell company status where equity value precedes substantive operational scale.

财务健康

The company reports no revenue, net income, or EBITDA figures for the trailing twelve months, a status that reveals a cost structure devoid of traditional operating expenses but entirely dependent on transaction-related costs until a merger is consummated. Similarly, the free cash flow is not available, indicating that the company currently possesses no operational cash flow flexibility and relies on its trust account or capital markets for liquidity. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which mathematically indicates that the company has not yet generated positive earnings from sales or operations to sustain a profitable margin structure. The balance sheet presents a specific debt obligation of $171,939 against an unspecified cash balance, with a price to book ratio of -1982.00, suggesting a highly leveraged or structurally unique capitalization common in SPACs before merger completion. The debt-to-equity ratio, current ratio, return on equity, and return on assets are all listed as not applicable, meaning no comparative leverage or liquidity data exists to assess short-term solvency or management effectiveness in terms of asset returns. Consequently, the financial health profile is defined by its potential for capital restructuring through a merger rather than current balance sheet strength derived from organic growth.

估值评估

The trailing P/E ratio and forward P/E ratio are both not available, which implies that there are no established earnings trajectories to evaluate against market expectations for future performance. The price-to-book ratio is reported at -1982.00, a figure that indicates a significant deviation from standard valuation norms where market premium over book value is positive, reflecting the speculative nature of the shell entity's equity relative to its nominal book value. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also not available, suggesting that traditional multiples cannot be applied to assess the company's intrinsic value without a completed transaction. The 52-week high is recorded at $10.04 and the 52-week low at $9.90, meaning the current market price sits within a very narrow trading range near the lower bound of the annual volatility band. The beta value is not applicable, which precludes a direct comparison of the stock's price volatility relative to the broader market index as the stock exhibits characteristics distinct from established operating companies.

Growth & Income

The revenue growth year-over-year and earnings growth year-over-year are both not applicable, indicating that the company has not yet achieved a growth phase where earnings expand faster or slower than revenue in a traditional operating context. As the company does not pay a dividend yield or maintain a payout ratio, it does not distribute income to shareholders but instead retains capital for potential business combination transactions. This reinvestment strategy aligns with the operational model of a shell company where earnings are theoretically directed toward deal-making activities rather than shareholder payouts. The overall growth and income profile is characterized by a lack of historical growth data and income distribution, focusing entirely on the potential for capital appreciation upon the successful execution of a merger or acquisition.

同行比较

Daedalus Special Acquisition Corp. (DSAC) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Daedalus Special Acquisition Corp. DSAC $338.82M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Daedalus Special Acquisition Corp.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Daedalus Special Acquisition Corp.

Daedalus Special Acquisition Corp. does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Daedalus Special Acquisition Corp. was incorporated in 2025 and is based in London, United Kingdom.

公司简介以英文显示。

关键指标

市值
$338.82M
市盈率
N/A
52周最高
$10.04
52周最低
$9.90
平均成交量
56.57K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United Kingdom